Skip to main content

Advertisement

SpringerLink
Log in

Surgical and other invasive approaches to recurrent pleural effusion with malignant etiology

  • Review Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

With an increasing number of cancer survivors, the annual incidence of malignant pleural effusions has been rising in recent decades worldwide. Many patients with various forms of cancer develop malignant pleural effusions at some point in their life. Patients most commonly present with progressive dyspnea. These effusions are refractory and are associated with impaired quality of life for these patients. The main goals of management are evacuation of the pleural fluid and prevention of its re-accumulation. The therapy plan should consider the general health of the patients, their performance status, the presence of trapped lung, and the primary malignancy. However, there is no universally established, standard approach. Surgical options include thoracentesis, chest tube drainage, thoracoscopy followed by chemical and mechanical pleurodesis, Pleur-X catheter drainage, and pleurectomy. Chemical pleurodesis is the most common modality of therapy for patients with recurrent pleural effusion. For example, Talc is the most successful pleurodesis agent with similar equal to that of poudrage or slurry. Pleur-X catheter can reduce hospital stay and adds value to the treatment of patients with trapped lung, who are not appropriate candidates for pleurodesis. Furthermore, a mechanical pleurodesis has been shown to be effective particularly in pleural effusions with lower pH. This article reviews the surgical and other invasive options as well as their technical aspects in the management of recurrent malignant pleural effusions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. American Thoracic Society (2000) Management of malignant pleural effusions. Am J Respir Crit Care Med 162:1987–2001

    Google Scholar 

  2. Chernow B, Sahn SA (1977) Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med 63:695–702

    Article  PubMed  CAS  Google Scholar 

  3. de Groot M, Walther G (1998) Thoracoscopy in undiagnosed pleural effusions. S Afr Med J 88:706–711

    PubMed  Google Scholar 

  4. Martini N, Bains MS, Beattie EJ Jr (1975) Indications for pleurectomy in malignant effusion. Cancer 35:734–738

    Article  PubMed  CAS  Google Scholar 

  5. Lee YC, Yasay JR, Johnson JE, Parker RE, Thompson PJ, Lane KB, Light RW (2002) Comparing transforming growth factor-beta2, talc and bleomycin as pleurodesing agents in sheep. Respirology 7:209–216

    Article  PubMed  Google Scholar 

  6. Sahn SA (1998) Use of fibrinolytic agents in the management of complicated parapneumonic effusions and empyemas. Thorax 53(Suppl 2):S65–S72

    Article  PubMed  Google Scholar 

  7. Alexandrakis MG, Passam FH, Kyriakou DS, Bouros D (2004) Pleural effusions in hematologic malignancies. Chest 125:1546–1555

    Article  PubMed  Google Scholar 

  8. Hausheer FH, Yarbro JW (1985) Diagnosis and treatment of malignant pleural effusion. Semin Oncol 12:54–75

    PubMed  CAS  Google Scholar 

  9. Sahn SA (1998) Malignancy metastatic to the pleura. Clin Chest Med 19:351–361

    Article  PubMed  CAS  Google Scholar 

  10. Thomas P, Robinet G, Gouva S, Fournel P, Lena H, Le Caer H, Perol M, Berard H, Bombaron P, Vergnenegre A, Kleisbauer JP (2006) Randomized multicentric phase II study of carboplatin/gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer GFPC 99-01 study (Groupe francais de pneumo-cancerologie). Lung Cancer 51:105–114

    Article  PubMed  CAS  Google Scholar 

  11. O’Brien ME, Watkins D, Ryan C, Priest K, Corbishley C, Norton A, Ashley S, Rowell N, Sayer R (2006) A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: the MED trial. Ann Oncol 17:270–275

    Article  PubMed  CAS  Google Scholar 

  12. Tremblay A, Michaud G (2006) Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest 129:362–368

    Article  PubMed  Google Scholar 

  13. Barbetakis N, Antoniadis T, Tsilikas C (2004) Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer. World J Surg Oncol 2:16

    Article  PubMed  Google Scholar 

  14. Gasparri R, Leo F, Veronesi G, DePas T, Colleoni M, Maisonneuve P, Pelosi G, Galimberti V, Spaggiari L (2006) Video-assisted management of malignant pleural effusion in breast carcinoma. Cancer 106:271–276

    Article  PubMed  Google Scholar 

  15. Fentiman IS, Millis R, Sexton S, Hayward JL (1981) Pleural effusion in breast cancer: a review of 105 cases. Cancer 47:2087–2092

    Article  PubMed  CAS  Google Scholar 

  16. Mentzer SJ, Reilly JJ, Skarin AT, Sugarbaker DJ (1993) Patterns of lung involvement by malignant lymphoma. Surgery 113:507–514

    PubMed  CAS  Google Scholar 

  17. Neragi-Miandoab S (2006) Malignant pleural effusion, current and evolving approaches for its diagnosis and management. Lung Cancer 54:1–9

    Article  PubMed  Google Scholar 

  18. Martinez-Moragon E, Aparicio J, Sanchis J, Menendez R, Cruz Rogado M, Sanchis F (1998) Malignant pleural effusion: prognostic factors for survival and response to chemical pleurodesis in a series of 120 cases. Respiration 65:108–113

    Article  PubMed  CAS  Google Scholar 

  19. Gao Z, Deng X, Cao Z (1998) Pulmonary lymphangitic carcinomatosis. Zhonghua Jiehe He Huxi Zazhi 21:739–741

    PubMed  CAS  Google Scholar 

  20. Bassiri AG, Morris W, Kirsch CM (1997) Eosinophilic tuberculous pleural effusion. West J Med 166:277–279

    PubMed  CAS  Google Scholar 

  21. Dabaja BS, Ha CS, Thomas DA, Wilder RB, Gopal R, Cortes J, Bueso-Ramos C, Hess MA, Cox JD, Kantarjian HM (2002) The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma. Cancer 94:2738–2744

    Article  PubMed  Google Scholar 

  22. Das DK (2006) Serous effusions in malignant lymphomas: a review. Diagn Cytopathol 34:335–347

    Article  PubMed  Google Scholar 

  23. Aquino SL, Chen MY, Kuo WT, Chiles C (1999) The CT appearance of pleural and extrapleural disease in lymphoma. Clin Radiol 54:647–650

    Article  PubMed  CAS  Google Scholar 

  24. Xaubet A, Diumenjo MC, Marin A, Montserrat E, Estopa R, Llebaria C, Austi A, Rozman C (1985) Characteristics and prognostic value of pleural effusions in non-Hodgkin’s lymphomas. Eur J Respir Dis 66:135–140

    PubMed  CAS  Google Scholar 

  25. Woodring JH (1984) Recognition of pleural effusion on supine radiographs: how much fluid is required? AJR Am J Roentgenol 142:59–64

    PubMed  CAS  Google Scholar 

  26. Jimenez D, Diaz G, Gil D, Cicero A, Perez-Rodriguez E, Sueiro A, Light RW (2005) Etiology and prognostic significance of massive pleural effusions. Respir Med 99:1183–1187

    Article  PubMed  Google Scholar 

  27. Sahn SA (1993) An undiagnosed pleural effusion. Hosp Pract (Off Ed) 28:60–64, 67; discussion 67–68

    CAS  Google Scholar 

  28. O’Donovan PB, Eng P (1994) Pleural changes in malignant pleural effusions: appearance on computed tomography. Clevel Clin J Med 61:127–131; quiz 162

    CAS  Google Scholar 

  29. Grogan DR, Irwin RS, Channick R, Raptopoulos V, Curley FJ, Bartter T, Corwin RW (1990) Complications associated with thoracentesis. A prospective, randomized study comparing three different methods. Arch Intern Med 150:873–877

    Article  PubMed  CAS  Google Scholar 

  30. Sorensen PG, Svendsen TL, Enk B (1984) Treatment of malignant pleural effusion with drainage, with and without instillation of talc. Eur J Respir Dis 65:131–135

    PubMed  CAS  Google Scholar 

  31. Groth G, Gatzemeier U, Haussingen K, Heckmayr M, Magnussen H, Neuhauss R, Pavel JV (1991) Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone versus placebo (pleural tube alone). Ann Oncol 2:213–215

    PubMed  CAS  Google Scholar 

  32. Krell WS, Rodarte JR (1985) Effects of acute pleural effusion on respiratory system mechanics in dogs. J Appl Physiol 59:1458–1463

    PubMed  CAS  Google Scholar 

  33. Sahn SA (1995) Pleural diagnostic techniques. Curr Opin Pulm Med 1:324–330

    PubMed  CAS  Google Scholar 

  34. Prakash UB, Reiman HM (1985) Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. Mayo Clin Proc 60:158–164

    PubMed  CAS  Google Scholar 

  35. Genc O, Petrou M, Ladas G, Goldstraw P (2000) The long-term morbidity of pleuroperitoneal shunts in the management of recurrent malignant effusions. Eur J Cardiothorac Surg 18:143–146

    Article  PubMed  CAS  Google Scholar 

  36. Light RW (1999) Useful tests on the pleural fluid in the management of patients with pleural effusions. Curr Opin Pulm Med 5:245–249

    Article  PubMed  CAS  Google Scholar 

  37. Heffner JE, Sahn SA, Brown LK (2002) Multilevel likelihood ratios for identifying exudative pleural effusions. Chest 121:1916–1920

    Article  PubMed  Google Scholar 

  38. Tarver RD, Broderick LS, Conces DJ Jr (1996) Reexpansion pulmonary edema. J Thorac Imaging 11:198–209

    PubMed  CAS  Google Scholar 

  39. Nakamura H, Ishizaka A, Sawafuji M, Urano T, Fujishima S, Sakamaki F, Sayama K, Kawamura M, Kato R, Kikuchi K (1994) Elevated levels of interleukin-8 and leukotriene B4 in pulmonary edema fluid of a patient with reexpansion pulmonary edema. Am J Respir Crit Care Med 149:1037–1040

    PubMed  CAS  Google Scholar 

  40. Sahn SA (2001) Management of malignant pleural effusions. Monaldi Arch Chest Dis 56:394–399

    PubMed  CAS  Google Scholar 

  41. Jay SJ (1986) Pleural effusions. 2. Definitive evaluation of the exudate. Postgrad Med 80:181–188

    PubMed  CAS  Google Scholar 

  42. Dev D, Basran GS (1994) Pleural effusion: a clinical review. Monaldi Arch Chest Dis 49:25–35

    PubMed  CAS  Google Scholar 

  43. Kennedy L, Sahn SA (1994) Noninvasive evaluation of the patient with a pleural effusion. Chest Surg Clin N Am 4:451–465

    PubMed  CAS  Google Scholar 

  44. Colice GL, Curtis A, Deslauriers J, Heffner J, Light R, Littenberg B, Sahn S, Weinstein RA, Yusen RD (2000) Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 118:1158–1171

    Article  PubMed  CAS  Google Scholar 

  45. Loddenkemper R (1998) Thoracoscopy—state of the art. Eur Respir J 11:213–221

    Article  PubMed  CAS  Google Scholar 

  46. Fetsch PA, Abati A (2001) Immunocytochemistry in effusion cytology: a contemporary review. Cancer 93:293–308

    Article  PubMed  CAS  Google Scholar 

  47. Fiegl M, Massoner A, Haun M, Sturm W, Kaufmann H, Hack R, Krugmann J, Fritzer-Szekeres M, Grunewald K, Gastl G (2004) Sensitive detection of tumour cells in effusions by combining cytology and fluorescence in situ hybridisation (FISH). Br J Cancer 91:558–563

    Article  PubMed  CAS  Google Scholar 

  48. Putnam JB Jr, Light RW, Rodriguez RM, Ponn R, Olak J, Pollak JS, Lee RB, Payne DK, Graeber G, Kovitz KL (1999) A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 86:1992–1999

    Article  PubMed  Google Scholar 

  49. Daniel TM (1993) Diagnostic thoracoscopy for pleural disease. Ann Thorac Surg 56:639–640

    Article  PubMed  CAS  Google Scholar 

  50. Ruckdeschel JC (1995) Management of malignant pleural effusions. Semin Oncol 22:58–63

    PubMed  CAS  Google Scholar 

  51. McKneally MF, Lewis RJ, Anderson RJ, Fosburg RG, Gay WA Jr, Jones RH, Orringer MB (1992) Statement of the AATS/STS Joint Committee on Thoracoscopy and Video Assisted Thoracic Surgery. J Thorac Cardiovasc Surg 104:1

    PubMed  CAS  Google Scholar 

  52. de Campos JR, Vargas FS, de Campos Werebe E, Cardoso P, Teixeira LR, Jatene FB, Light RW (2001) Thoracoscopy talc poudrage: a 15-year experience. Chest 119:801–806

    Article  PubMed  Google Scholar 

  53. Ukale V, Bone D, Hillerdal G, Cederlund K, Widstrom O, Larsen F (1999) The impact of pleurodesis in malignant effusion on respiratory function. Respir Med 93:898–902

    Article  PubMed  CAS  Google Scholar 

  54. Perpina M, Benlloch E, Marco V, Abad F, Nauffal D (1983) Effect of thoracentesis on pulmonary gas exchange. Thorax 38:747–750

    PubMed  CAS  Google Scholar 

  55. Rodriguez-Panadero F (2000) Malignant pleural diseases. Monaldi Arch Chest Dis 55:17–19

    PubMed  CAS  Google Scholar 

  56. Hausheer FH, Yarbro JW (1987) Diagnosis and treatment of malignant pleural effusion. Cancer Metastasis Rev 6:23–40

    Article  PubMed  CAS  Google Scholar 

  57. Villanueva AG, Gray AW Jr, Shahian DM, Williamson WA, Beamis JF Jr (1994) Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions. Thorax 49:23–25

    Article  PubMed  CAS  Google Scholar 

  58. Lorch DG, Gordon L, Wooten S, Cooper JF, Strange C, Sahn SA (1988) Effect of patient positioning on distribution of tetracycline in the pleural space during pleurodesis. Chest 93:527–529

    Article  PubMed  CAS  Google Scholar 

  59. Yim AP, Chung SS, Lee TW, Lam CK, Ho JK (1996) Thoracoscopic management of malignant pleural effusions. Chest 109:1234–1238

    Article  PubMed  CAS  Google Scholar 

  60. Sahn SA, Good JT Jr (1988) Pleural fluid pH in malignant effusions. Diagnostic, prognostic, and therapeutic implications. Ann Intern Med 108:345–349

    PubMed  CAS  Google Scholar 

  61. Wong PS, Goldstraw P (1993) Pleuroperitoneal shunts. Br J Hosp Med 50:16–21

    PubMed  CAS  Google Scholar 

  62. Grossi F, Pennucci MC, Tixi L, Cafferata MA, Ardizzoni A (1998) Management of malignant pleural effusions. Drugs 55:47–58

    Article  PubMed  CAS  Google Scholar 

  63. Antunes G, Neville E (2000) Management of malignant pleural effusions. Thorax 55:981–983

    Article  PubMed  CAS  Google Scholar 

  64. Walker-Renard PB, Vaughan LM, Sahn SA (1994) Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 120:56–64

    PubMed  CAS  Google Scholar 

  65. Webb WR, Ozmen V, Moulder PV, Shabahang B, Breaux J (1992) Iodized talc pleurodesis for the treatment of pleural effusions. J Thorac Cardiovasc Surg 103:881–885; discussion 885–886

    PubMed  CAS  Google Scholar 

  66. Dresler CM, Olak J, Herndon JE II, Richards WG, Scalzetti E, Fleishman SB, Kernstine KH, Demmy T, Jablons DM, Kohman L, Daniel TM, Haasler GB, Sugarbaker DJ (2005) Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 127:909–915

    Article  PubMed  Google Scholar 

  67. Bouchama A, Chastre J, Gaudichet A, Soler P, Gibert C (1984) Acute pneumonitis with bilateral pleural effusion after talc pleurodesis. Chest 86:795–797

    Article  PubMed  CAS  Google Scholar 

  68. Rinaldo JE, Rogers RM (1986) Adult respiratory distress syndrome. N Engl J Med 315:578–580

    Article  PubMed  CAS  Google Scholar 

  69. Kennedy L, Rusch VW, Strange C, Ginsberg RJ, Sahn SA (1994) Pleurodesis using talc slurry. Chest 106:342–346

    Article  PubMed  CAS  Google Scholar 

  70. Ferrer J, Villarino MA, Tura JM, Traveria A, Light RW (2001) Talc preparations used for pleurodesis vary markedly from one preparation to another. Chest 119:1901–1905

    Article  PubMed  CAS  Google Scholar 

  71. Thompson RL, Yau JC, Donnelly RF, Gowan DJ, Matzinger FR (1998) Pleurodesis with iodized talc for malignant effusions using pigtail catheters. Ann Pharmacother 32:739–742

    Article  PubMed  CAS  Google Scholar 

  72. Marom EM, Patz EF Jr, Erasmus JJ, McAdams HP, Goodman PC, Herndon JE (1999) Malignant pleural effusions: treatment with small-bore-catheter thoracostomy and talc pleurodesis. Radiology 210:277–281

    PubMed  CAS  Google Scholar 

  73. Erickson KV, Yost M, Bynoe R, Almond C, Nottingham J (2002) Primary treatment of malignant pleural effusions: video-assisted thoracoscopic surgery poudrage versus tube thoracostomy. Am Surg 68:955–959; discussion 959–960

    PubMed  Google Scholar 

  74. Trotter D, Aly A, Siu L, Knight S (2005) Video-assisted thoracoscopic (VATS) pleurodesis for malignant effusion: an Australian teaching hospital’s experience. Heart Lung and Circulation 14:93–97

    Article  Google Scholar 

  75. Mitrofan C, Aldea A, Grigorescu C, Jitaru I, Iosep G, Arama A, Danciu CE, Bolog S, Mihaescu T (2005) Thoracoscopic pleurodesis in malignant pleural effusions. Rev Med Chir Soc Med Nat Iasi 109:799–803

    PubMed  CAS  Google Scholar 

  76. Gasparri R, Leo F, Veronesi G, De Pas T, Colleoni M, Maisonneuve P, Pelosi G, Galimberti V, Spaggiari L (2006) Video-assisted management of malignant pleural effusion in breast carcinoma. Cancer 106:271–276

    Article  PubMed  Google Scholar 

  77. Marrazzo A, Noto A, Casa L, Taormina P, Lo Gerfo D, David M, Mercadante S (2005) Video-thoracoscopic surgical pleurodesis in the management of malignant pleural effusion: the importance of an early intervention. J Pain Symptom Manage 30:75–79

    Article  PubMed  Google Scholar 

  78. Arapis K, Caliandro R, Stern JB, Girard P, Debrosse D, Gossot D (2006) Thoracoscopic palliative treatment of malignant pleural effusions: results in 273 patients. Surg Endosc 20:919–923

    Article  PubMed  CAS  Google Scholar 

  79. Gu LJ, Wang WJ (2006) Comparative study of video-assisted thoracoscopic surgery vs thoracic tube drainage in synthetic therapy for malignant pleural effusion secondary to non-small cell lung cancer. Nan Fang Yi Ke Da Xue Xue Bao 26:1023–1026

    PubMed  Google Scholar 

  80. Luh SP, Chen CY, Tzao CY (2006) Malignant pleural effusion treatment outcomes: pleurodesis via video-assisted thoracic surgery (VATS) versus tube thoracostomy. Thorac Cardiovasc Surg 54:332–336

    Article  PubMed  Google Scholar 

  81. Crnjac A (2004) The significance of thoracoscopic mechanical pleurodesis for the treatment of malignant pleural effusions. Wien Klin Wochenschr 116(Suppl 2):28–32

    PubMed  Google Scholar 

  82. Maier A, Anegg U, Renner H, Tomaselli F, Fell B, Lunzer R, Sankin O, Pinter H, Friehs GB, Smolle-Juttner FM (2000) Four-year experience with pleural abrasion using a rotating brush during video-assisted thoracoscopy. Surg Endosc 14:75–78

    Article  PubMed  CAS  Google Scholar 

  83. Burgers JA, Olijve A, Baas P (2006) Chronic indwelling pleural catheter for malignant pleural effusion in 25 patients. Ned Tijdschr Geneeskd 150:1618–1623

    PubMed  CAS  Google Scholar 

  84. Brubacher S, Gobel BH (2003) Use of the Pleurx Pleural Catheter for the management of malignant pleural effusions. Clin J Oncol Nurs 7:35–38

    Article  PubMed  Google Scholar 

  85. van den Toorn LM, Schaap E, Surmont VF, Pouw EM, van der Rijt KC, van Klaveren RJ (2005) Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter. Lung Cancer 50:123–127

    Article  PubMed  Google Scholar 

  86. Musani AI, Haas AR, Seijo L, Wilby M, Sterman DH (2004) Outpatient management of malignant pleural effusions with small-bore, tunneled pleural catheters. Respiration 71:559–566

    Article  PubMed  Google Scholar 

  87. Putnam JB Jr, Walsh GL, Swisher SG, Roth JA, Suell DM, Vaporciyan AA, Smythe WR, Merriman KW, DeFord LL (2000) Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg 69:369–375

    Article  PubMed  Google Scholar 

  88. Rusch VW (1997) Pleurectomy/decortication in the setting of multimodality treatment for diffuse malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg 9:367–372

    PubMed  CAS  Google Scholar 

  89. Pass HI, Pogrebniak HW (1993) Malignant pleural mesothelioma. Curr Probl Surg 30:921–1012

    Article  PubMed  CAS  Google Scholar 

  90. Pass HI, Temeck BK, Kranda K, Steinberg SM, Feuerstein IR (1998) Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 115:310–317; discussion 317–318

    Article  PubMed  CAS  Google Scholar 

  91. Brancatisano RP, Joseph MG, McCaughan BC (1991) Pleurectomy for mesothelioma. Med J Aust 154:455–457, 460

    PubMed  CAS  Google Scholar 

  92. Waller DA, Morritt GN, Forty J (1995) Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion. Chest 107:1454–1456

    Article  PubMed  CAS  Google Scholar 

  93. Anderson CB, Philpott GW, Ferguson TB (1974) The treatment of malignant pleural effusions. Cancer 33:916–922

    Article  PubMed  CAS  Google Scholar 

  94. Aelony Y (2003) Dry talc pleurodesis via chest tube. Chest 123:308 (author reply 308)

    Article  PubMed  Google Scholar 

  95. Aelony Y (1998) Cost-effective pleurodesis. Chest 113:1731–1732

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

I would like to thank Christine Leigh Gosen for her technical support. Christine is currently a senior medical student at Case Western Reserve University, School of Medicine.

Author information

Authors and Affiliations

  1. Department of Surgery, School of Medicine, Case Western Reserve University, 11100 Euclid Ave. LKS 7109, Cleveland, OH, USA

    Siyamek Neragi-Miandoab

Authors
  1. Siyamek Neragi-Miandoab
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Siyamek Neragi-Miandoab.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Neragi-Miandoab, S. Surgical and other invasive approaches to recurrent pleural effusion with malignant etiology. Support Care Cancer 16, 1323–1331 (2008). https://doi.org/10.1007/s00520-008-0405-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-008-0405-5

Keywords

Search

Navigation